Status:

COMPLETED

CONCERTA® (Methylphenidate Hydrochloride) as add-on Therapy in the Treatment of Adult Major Depressive Disorder.

Lead Sponsor:

Janssen-Ortho Inc., Canada

Conditions:

Depressive Disorder, Major

Eligibility:

All Genders

18-65 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to evaluate the effects of the addition of CONCERTA® (methylphenidate hydrochloride, a central nervous system (CNS) stimulant) or placebo in adult outpatients with Major D...

Detailed Description

Patient response to antidepressant therapy is low and 10-30% of depressed patients fail to respond to antidepressant therapy and of those patients who do respond, 50-75% exhibit a partial response. Au...

Eligibility Criteria

Inclusion

  • Currently having a Major Depressive Disorder episode without psychotic features
  • Has had an inadequate response to at least one but not more than 3 antidepressants given for 4 weeks
  • Is currently treated with an antidepressant for the past 4 weeks
  • Has a Montgomery Asberg Depression Rating Scale (MADRS) total score greater than or equal to 20, lassitude score of greater than or equal to 2 and a suicidal thought score less than 4
  • Has a Clinical Global Impression of Severity (CGI-S) score greater than or equal to 4

Exclusion

  • Has a current diagnosis of schizophrenia, bipolar disorder, dementia, psychosis, obsessive-compulsive disorder, post-traumatic stress disorder, panic disorder, Attention Deficit Hyperactivity Disorder (ADHD), anorexia nervosa and/or bulimia nervosa, or a history of ADHD, anorexia nervosa and/or bulimia nervosa
  • Agitated during the current depressive episode
  • Has significant abnormal personality traits, which could interfere with function
  • Has a history of substance abuse and or dependence within 6 months prior to screening

Key Trial Info

Start Date :

June 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2006

Estimated Enrollment :

145 Patients enrolled

Trial Details

Trial ID

NCT00246233

Start Date

June 1 2005

End Date

April 1 2006

Last Update

May 17 2011

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

CONCERTA® (Methylphenidate Hydrochloride) as add-on Therapy in the Treatment of Adult Major Depressive Disorder. | DecenTrialz